[1] PEROU CM, SORLIE T, EISEN MB, et al. Molecular portraits of human breast tumors[J]. Nature, 2000, 406(6797): 747. doi: 10.1038/35021093
[2] GNANT M, HARBECK N, THOMSSEN C, et al. Summary of the Consensus Discussion[J]. Breast Care, 2011, 6(2): 136. doi: 10.1159/000328054
[3] MAITLAND ML, SCHILSKY RL. Clinical trials in the era of personalized oncology[J]. CA Cancer J Clin, 2011, 61(6): 365. doi: 10.3322/caac.20135
[4] CHEANG MC, VODUC D, BAJDIK C, et al. Basal like breast cancer defined by five bio markers has superior prognostic value than triple negative phenotype[J]. Clin Cancer Res, 2008, 14(5): 1368. doi: 10.1158/1078-0432.CCR-07-1658
[5] LIN NU, VANDERPLAS A, HUGHES ME, et al. Clinicopathologic features of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network[J]. Cancer, 2012, 118(22): 5463. doi: 10.1002/cncr.27581
[6] 邱镜丹, 马振海, 马金辉, 等. 三阴性与非三阴性乳腺癌临床病理特征及预后比较[J]. 中华内分泌外科杂志, 2012, 6(5): 313. doi: 10.3760/cma.j.issn.1674-6090.2012.05.007
[7] 李玉龙, 彭德峰, 王自豪, 等. 三阴性乳腺癌210例临床分析[J]. 蚌埠医学院学报, 2019, 44(9): 1173.
[8] HALDER G, JOHNSON RL. Hippo signaling: growth control and beyond[J]. Development, 2011, 138(1): 9. doi: 10.1242/dev.045500
[9] DIAZ-MARTIN J, LOPEZ-GARCIA MA, ROMERO-PEREZ L, et al. Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer[J]. Endocr Relat Cancer, 2015, 22(3): 443. doi: 10.1530/ERC-14-0456
[10] LIU Y, REN M, TAN X, et al. Distinct changes in the expression TAZ are associated with normal cervix and human cervical cancer[J]. J Cancer, 2018, 9(22): 4263. doi: 10.7150/jca.26623
[11] OUYANG T, MENG W, LI M, et al. Recent advances of the Hippo/YAP signaling pathway in brain development and glioma[J]. Cell Mol Neurobiol, 2019, 302(2): 1.
[12] GUO P, KANG S, ZHAO F. High expression of TAZ/YAP promotes the progression of malignant melanoma and affects the postoperative survival of patients[J]. Pharmazie, 2018, 73(11): 662.
[13] WANG S, MA K, CHEN L, et al. TAZ promotes cell growth and inhibits Celastrol-induced cell apoptosis[J]. Biosci Rep, 2016, 36(5): e00386. doi: 10.1042/BSR20160135
[14] LI Z, WANG Y, ZHU Y, et al, The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer[J]. Mol Oncol, 2015, 9(6): 1091. doi: 10.1016/j.molonc.2015.01.007
[15] KIM S, AN SS. Role of p53 isoforms and aggregations in cancer[J]. Medicine, 2016, 95(26): e3993. doi: 10.1097/MD.0000000000003993
[16] LI JP, ZHANG XM, ZHANG Z, et al. Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma[J]. Medicine, 2019, 98(18): e15449. doi: 10.1097/MD.0000000000015449